Wed.Jun 01, 2022

article thumbnail

Bristol Myers' autoimmune drug shows potential in lupus

Bio Pharma Dive

Positive Phase 2 results could help boost company executives' arguments that the drug, called deucravacitinib and under FDA review in psoriasis, will become a top-seller.

Drugs 337
article thumbnail

Insurance companies putting profits ahead of patients

World of DTC Marketing

Five of America’s largest health insurers reported more than $11bn in profits in the second quarter – a decline from the same period last year when the Covid-19 pandemic helped drive sky-high profits yet they are having more of a say on patients’ treatments even when HCPs disagree. A vibrant 83-year-old man hurt his back while gardening. His neurologist diagnosed the problem as a disk issue that could be fixed with surgery.

Doctors 225
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sage, Biogen drug meets goal in postpartum depression study

Bio Pharma Dive

The results will help support an application for FDA approval, which the companies plan to submit early next year. They are already seeking an OK for their treatment in major depressive disorder.

article thumbnail

Could virtual reality become an essential tool for healthcare education?

pharmaphorum

The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. In this article, Ben Hargreaves looks at how VR headsets are being used to better educate both healthcare professionals and the general public. Digital healthcare solutions are being talked about with increasing frequency.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Pfizer to exit GSK consumer health joint venture after spinoff

Bio Pharma Dive

The pharma currently holds a 32% stake in the business, which is set to become a standalone company that will trade on the London Stock Exchange beginning in July.

141
141
article thumbnail

mRNA tech ‘reason for hope’ on path to HIV vaccine

BioPharma Reporter

With mRNA tech achieving major success against COVID-19, the initiation of trials into vaccination against HIV is creating discussion amid a potential breakthrough in the prevention of the disease.

More Trending

article thumbnail

AstraZeneca CEO Knighted by Queen for COVID-19 Leadership

BioSpace

AstraZeneca CEO Pascal Soriot has been knighted in the Queen's Birthday Honours for his contribution to life sciences and leadership during the COVID-19 pandemic.

article thumbnail

Boosting innovation in antibacterials: Pitfalls and potential solutions

BioPharma Reporter

A well-funded and appropriately rewarded biotech ecosystem is needed for the next generation of antibacterials to reach the clinic and beyond, according to BIOâs State of Innovation in Antibacterial Therapeutics report.

article thumbnail

BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US

XTalks

BONESUPPORT received market authorization from the FDA for Cerament G, the first and only bone graft with antibiotic elution that is approved for the US market. Osteomyelitis is a bone infection caused by fungi or bacteria. Individuals at risk for developing osteomyelitis include those with a weak immune system, traumatic injury or wound, pressure injuries, artificial joints (like hip replacements) or metal implants in bone, blood infection and diabetes.

Filler 98
article thumbnail

Astellas taps GO’s glycoprotein platform with $783.5m deal

pharmaphorum

Astellas has become the latest big pharma company to sink some money into immuno-oncology start-up GO Therapeutics, forging an alliance to develop antibodies targeting two glycoprotein targets. The Japanese drugmaker is paying $20.5 million upfront to get the ball rolling, while milestone and other payments could take the total value of the deal up to $783.5 million.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

How to Attract and Keep Top Talent in the Pharma Industry

BioSpace

The increased resignation of employees is making it difficult for companies to keep up with production and meet deadlines. Here are the best ways to attract and keep top talent in the pharma industry.

article thumbnail

Xtalks Voices Featuring Advances in Oncology Imaging with Dr. Edward Ashton

XTalks

In this exclusive Xtalks Voices feature, hear from Dr. Edward Ashton, PhD, VP, Oncology Imaging, Philips BioTel Research, about the latest advancements in oncology imaging powered by the integration of new technologies like artificial intelligence. Watch the video here: Xtalks Voices with Imaging Oncology expert Dr. Edward Ashton from Phillips BioTel Research.

article thumbnail

How Lithuania aims to become a leading European biotech hub

BioPharma Reporter

Lithuaniaâs life sciences industry is growing at one of the fastest rates in Europe. Ahead of BIO, Innovation Agency Lithuania explains what the countryâs plans are for future growth in the area and how this is built upon students heading into STEM studies.

article thumbnail

Median Tech debuts AI-focused unit for cancer trial support

pharmaphorum

Medical imaging specialist Median Technologies has launched a new business unit that will provide decision-making tools – underpinned by artificial intelligence – for sponsors of clinical trials in oncology. The new Imaging Lab business will deploy AI, data mining, and radiomics technologies to medical imaging data generated in cancer trials, said Median.

Trials 98
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

IMDEA Software will be part of the four digitization clusters in the Madrid region dedicated to blockchain, AI, digital transformation and IoT

Scienmag

The Madrid Regional Government culminates the opening of the last of the four digitization clusters in the region dedicated to Blockchain (Tres Cantos), Artificial Intelligence (Leganés), Digital Transformation (Torrejón de Ardoz) and Internet of Things (Las Rozas). Professionals from 57 leading national and international companies, organizations and entities, including the IMDEA Software Institute, comprise the clusters team […].

95
article thumbnail

Outbreak Updates: Monkeypox Highlights Animal-to-Human Interface, Dogs Sniff Out COVID-19

BioSpace

Monkeypox is not COVID-19, but both are viral diseases that are front-and-center in the world of public health and epidemiology. Here's a look at the latest news on both outbreaks.

98
article thumbnail

Scaling new heights with new research showing how plants can grow at altitude

Scienmag

A new study has found that plant species are adapted to the altitude where they grow by ‘sensing’ the oxygen levels that surround them. Credit: Cristian Miño A new study has found that plant species are adapted to the altitude where they grow by ‘sensing’ the oxygen levels that surround them. Altitude is an important part of plant ecology […].

article thumbnail

J&J and BMS Drugs Reduce COVID-19 Deaths in Moderate-to-Severe Population

BioSpace

Bristol Myers Squibb’s Orencia and Johnson & Johnson’s Remicade improved survival rates for people hospitalized with COVID-19 according to a new report by the National Institutes of Health.

Drugs 111
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Major climate benefits when ships “fly” over the surface

Scienmag

Soon, electric passenger ferries skimming above the surface across the seas may become a reality. At Chalmers University of Technology, Sweden, a research team has created a unique method for further developing hydrofoils that can significantly increase the range of electric vessels and reduce the fuel consumption of fossil-powered ships by 80 per cent. […].

article thumbnail

Bio International Convention 2022: Program highlights

BioPharma Reporter

From the future of RNA to the applications of AI in drug development, hereâs 10 of the top sessions for biopharma pros at BIO in San Diego this month.

RNA 102
article thumbnail

New genomic tools shed light on the evolutionary history of chimpanzees and contribute to their conservation

Scienmag

Chimpanzees inhabit the tropical African savannah-woodlands and forests. In contrast to the hominid sites preserved to this day – mainly in caves and temperate climates – the areas that chimpanzees have inhabited have resulted in few specimens preserved or detected in the archaeological record. Given the absence of chimpanzee fossils, the genetic information from current […].

Genome 88
article thumbnail

Seattle’s Sana Biotech Shifts Manufacturing to Bothell, Washington, Adds Key Leaders

BioSpace

Seattle-based Sana Biotechnology is moving on from its current Fremont, California manufacturing facility, inking a lease deal to develop a manufacturing plant in Bothell, Washington.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Small, rare crayfish thought extinct is rediscovered in cave in Huntsville city limits

Scienmag

HUNTSVILLE, Ala. (June 1, 2022) – A small, rare crayfish thought to be extinct for 30 years has been rediscovered in a cave in the City of Huntsville in northern Alabama by a team led by an assistant professor at The University of Alabama in Huntsville (UAH). Credit: Amata Hinkle HUNTSVILLE, Ala. (June 1, 2022) […].

article thumbnail

NICE recommends UCB’s Fintepla for Dravet syndrome

Pharma Times

The drug is used to treat seizures caused by this rare syndrome that is a form of epilepsy

Drugs 118
article thumbnail

MDI Biological Laboratory scientist helping to develop the axolotl as a model

Scienmag

BAR HARBOR, MAINE – With its amazing capacity to regenerate tissues and organs, its ability to reproduce in a laboratory environment and the ease with which its genes can be manipulated, the Mexican salamander, or axolotl, holds enormous promise as a model for the study of regenerative medicine. Credit: MDI Biological Laboratory BAR HARBOR, MAINE […].

article thumbnail

Teva UK introduces first generic oral anticoagulant

Pharma Times

Apixaban will be available for the prevention of stroke and deep vein thrombosis

125
125
article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Antibiotics wreak havoc on athletic performance

Scienmag

New research demonstrates that by killing essential gut bacteria, antibiotics ravage athletes’ motivation and endurance. The UC Riverside-led mouse study suggests the microbiome is a big factor separating athletes from couch potatoes. Credit: Monica McNamara/UCR New research demonstrates that by killing essential gut bacteria, antibiotics ravage athletes’ motivation and endurance.

article thumbnail

Roche, Repare Ink $1.2B Deal for Development of Cancer Therapy

BioSpace

Repare Therapeutics announced a global cancer collaboration valued at up to $1.2 billion with Swiss pharma giant Roche for the development and commercialization of camonsertib.

article thumbnail

A stem cell model from Mount Sinai could help unravel the complex biology behind some psychiatric disorders

Scienmag

Researchers from the Icahn School of Medicine at Mount Sinai have applied a novel stem cell model to map disease risk variants in human neurons, which could help provide insights into the biological mechanisms that underlie neuropsychiatric disorders such as autism and schizophrenia. Credit: Mount Sinai Health System Researchers from the Icahn School of Medicine […].

article thumbnail

Regeneron to Buy Sanofi’s Stake in Libtayo for $900M Upfront

BioSpace

Regeneron Pharmaceuticals announced intentions to acquire Sanofi’s stake in a drug they developed together, Libtayo (cemiplimab).

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.